CClinicalTrials.gg
CompletedNCT05510232Updated Jan 31, 2025Results posted

Virtual Reality Distraction During Outpatient Pediatric Orthopedic Procedures

An interventional study of A treatment group that will watch a non-VR video via an iPad and A treatment group that will have headset on and will watch a non-VR video in Fractures, Bone and Deformity; Bone, sponsored by Hospital for Special Surgery, New York. Completed at 1 site in United States. Open to participants aged 4 Years to 14 Years. Per ClinicalTrials.gov, last updated 2025-01-31.

Sponsored by Hospital for Special Surgery, New York · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years after the study started (first participant enrolled Jul 2018, registered Aug 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
226
Allocation
Randomized
Ages
4 Years to 14 Years
Sex
All
01

Study summary

Virtual Reality(VR) has had promising applications in science and medicine, including intervention delivery. The use of VR interventions has been studied in a wide range of medical conditions, including anxiety, phobias, obesity, chronic pain, and eating disorders. VR based simulation in pediatrics has grown rapidly in recent years and is expected to continue to grow. VR technology has become increasingly affordable, flexible, and portable, enabling its use in a broad range of environments including the outpatient clinical setting. Additionally, children are believed to have an inclination toward games of "pretend" or alternate realities further indicating the potential of this technology. While immersed in a game, they often become deeply absorbed and able to ignore aversive stimuli. VR is an engaging intervention that may help to detract from pain and anxiety for children undergoing painful procedures. Heart rate has been used as a means to objectively quantify the physiologic response to pain and anxiety.

The purpose of the study is to conduct a randomized controlled study that assess the utility of Virtual Reality simulations compared to non immersive visual distraction in pediatric patients undergoing outpatient procedures including cast removal and surgical suture/pins removal. Primary outcomes will include changes in patient heart rate (an age-validated surrogate for pain and anxiety) and patient-reported changes in anxiety and pain. Secondary outcomes will include patient/parent-reported satisfaction.

Read the detailed description

Cast, pin and suture removal are involved in post-procedural pediatric orthopedic care. Although viewed as straightforward and routine parts of outpatient management, they may be viewed as painful, and serve as a source of anxiety for patients. A randomized control trial by Lim et al investigated the potential for analgesia to decrease the pain perception experienced during pin removal. The authors failed to identify a statistically significant decrease in heart rate and pain score during pin removal with ibuprofen or acetaminophen treatment compared to placebo. The failure of analgesia to produce a significant change in pain perception and heart rate of pediatric patients may indicate that there is a psychological component of this pain and anxiety that is poorly understood and can potentially be altered.

The absence of a standard intervention to decrease the morbidity associated with pin, suture and cast removal warrants further investigation into alternate interventions that could be helpful. The well described capacity of Virtual Reality to modulate subjective experiences especially in the pediatric population makes it a compelling intervention in the acute clinical setting. To date, no studies have explored the utilization of VR as a means of decreasing the morbidity associated with outpatient orthopedic interventions such as pin, suture and cast removal has currently not been investigated.

Virtual reality(VR) has garnered interest in a number of medical domains and clinical settings. VR technology has also proven efficacy in the domain of pain management and neurorehabilitation. VR has also found application in the pediatric population. VR has also been found useful as a distraction technique in acute care pediatric procedures such as phlebotomy. Schmitt et al investigated the use of VR in dressing changes for pediatric patients who had sustained burn wounds. Their work demonstrated a pain score reduction of 27-44% in pediatric patients who participated in the virtual reality gaming environment while undergoing dressing changes.

Casts, sutures and pins are often utilized as primary or adjunct interventions and removed weeks after the intended healing goals are met. In clinical practice, pain and anxiety are often experienced by pediatric patients during outpatient suture, pin or cast removal. Heart rate has been used extensively in the objective quantification of the pain response in the pediatric population. To capture the subjective sensation of pain and anxiety, the Visual Analog Scale (VAS) is pain scale is commonly utilized. Lim et al conducted a randomized control trials looking at the potential for analgesia to decrease the pain perception experienced during pin removal. The authors failed to identify a statistically significant decrease in the pain score with ibuprofen or acetaminophen treatment vs. placebo treatment. The failure of analgesia to produce a significant change in pain perception and heart rate of pediatric patients may indicate that the dissatisfaction related to the experience of pin or suture removal may not entirely be related to the parameters investigated by the study.

Similarly, casting is a routine procedure used for the treatment fractures in the pediatric population. Casting can be used to immobilize non-displaced fractures and stabilize the reduction of displaced fractures. Cast removal in the pediatric population can also be a challenge for patients, parents and providers. The fear and anxiety experienced by pediatric patients during cast removal can adversely impact the clinical encounter. Noise reduction and music therapy have been used for cast removal in pediatric patients have shown promise in smaller RCT's that have reported reduced heart rates during intervention delivery. Studies showing the efficacy of distraction techniques in decreasing patient pain and anxiety question if more immersive distractions, such virtual reality gaming, could have the potential to positively influence the the outpatient pediatric orthopedic experience.

The purpose of the study is to assess the utility of Virtual Reality simulations in pediatric patients undergoing outpatient interventions including cast and surgical suture/pins removal. Primary outcomes will include changes in patient heart rate and patient-reported changes in anxiety and pain with virtual reality assisted treatment. Secondary outcomes will include patient reported satisfaction and procedure disturbance count as quantified by the number of times a patient looks over at the site of intervention.

02

Conditions studied

  • Fractures, Bone
  • Deformity; Bone

Browse trials for

03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

This study's enrollment of 226 is above the median of 69 across 1,482 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 217 studies on the registry; 39 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 20 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

-All patients pediatric patients undergoing cast, pin and suture removal between the ages of 4 -14 years

Exclusion criteria

Exclusion Criteria:

  • History of epilepsy and seizures
  • Anxiety disorders documented
  • Unable to understand/follow VR directions
  • History of vertigo and/or dizziness
  • History of chronic pain
  • Non-English speakers
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
226 participants (actual)

Study arms

  • Experimental
    A treatment group that will watch a non-VR video via an iPad

    Demographic appropriate screening for inclusion ( including age and available past medical history) Patient consent (before randomization), iPad administration (description below), cast sawing, physical examination (before and after procedure), pulse oximetry application (HR measured 3 minutes pre-procedure and throughout entire procedure), NRS VAS pain administration (3 minutes pre-procedure and immediately post-procedure) in patients over 8 years(Will mark on scale), VAS Faces pain administration (3 minutes pre-procedure and immediately post-procedure) in patients under 8 years (Will point to face), NRS VAS anxiety administration (3 minutes pre-procedure and immediately post-procedure)(Will mark on scale), VAS Faces anxiety scale administration in patients under 8 years(Will point to face), Patient/parent satisfaction administration (post-procedure).

    Device: A treatment group that will watch a non-VR video via an iPad

  • Experimental
    A treatment group that will have headset on and will watch a VR video

    Demographic appropriate screening for inclusion ( including age and available past medical history) Patient consent (before randomization), Video administration via headset(description below), Cast sawing, Physical examination (before and after procedure), Pulse oximetry application (HR measured 3 minutes pre-procedure and throughout entire procedure), NRS VAS pain administration (3 minutes pre-procedure and immediately post-procedure) in patients over 8 years(Will mark on scale), VAS Faces pain administration (3 minutes pre-procedure and immediately post-procedure)in patients under 8 years(Will point to face), NRS VAS anxiety administration (3 minutes pre-procedure and immediately post-procedure)(Will mark on scale), VAS Faces anxiety administration (3 minutes pre-procedure and immediately post-procedure) in patients under 8 years (Will point to face), Patient/parent satisfaction administration (post-procedure).

    Device: A treatment group that will have headset on and will watch a non-VR video

  • Experimental
    A treatment group that will be immersed in the VR game (Bear Blast) via the headset.

    Demographic appropriate screening for inclusion ( including age and available past medical history) Patient consent (before randomization) VR assembly and administration (description below) Cast sawing, physical examination (before and after procedure) , pulse oximetry application (HR measured 3 minutes pre-procedure and throughout entire procedure), NRS VAS pain administration (3 minutes pre-procedure and immediately post-procedure) in patients over 8,-(Will mark on scale) VAS Faces pain administration (3 minutes pre-procedure and immediately post-procedure) in patients under 8 years(Will point to face), NRS VAS anxiety administration (3 minutes pre-procedure and immediately post-procedure)(Will mark on scale), VAS Faces anxiety scale administration (3 minutes pre-procedure and immediately post-procedure) in patients under 8 years(Will point to face), Patient/parent satisfaction administration (post-procedure).

    Device: A treatment group that will be immersed in the VR game (Bear Blast) via the headset.

Interventions

  • DeviceA treatment group that will watch a non-VR video via an iPad

    The iPad is a tablet computer first offered by Apple in 2010.The device resembles a much larger version of Apple's iPhone or its iPod Touch, and is about the same size as a magazine.The iPad uses the same operating system as the Apple iPhone, and uses very similar hardware. iPad will be used to deliver non VR video to patients. A standardized age appropriate video will be used for patients between ages 4-9 and a different standardized age appropriate video for patients ages 10-14. The selected videos will be the same for both the cast and suture/pin removal groups.

  • DeviceA treatment group that will have headset on and will watch a non-VR video

    Oculus headset will deliver VR video to patients. Headset will be administered before intervention and removed at the completion of the intervention unless patient requests otherwise. Patients visual field will not change with head motion and will remain static throughout cast removal or pin/suture removal. A standardized age appropriate video will be used for patients between ages 4-14. The selected videos will be the same for both the cast and suture/pin removal groups.

  • DeviceA treatment group that will be immersed in the VR game (Bear Blast) via the headset.

    VR using the Oculus headset will deliver VR images and sound. Patients will watch a 15-minute VR experience called Bear Blast. Bear Blast is an immersive, 360-degree, game experience that takes place in a fantasy world where the user attempts to shoot balls at a wide range of moving objects by gently maneuvering his or her head toward the targets. Bear Blast is a nonviolent and noncompetitive game that incorporates motivational music and features positively reinforcing sounds, animation, and direct messages to patients. Bear Blast will be used as the standardized game for all patients in the VR group of both study arms. The VR Oculus headset can be controlled entirely via head motion and does not involve the use of patients extremities.

06

What researchers measure

Primary outcomes

  1. Absolute Difference in HR as Measured 3 Minutes Prior to Procedure and Maximum as Measured During Through 1 Minute After Procedure.

    Pulse oximetry application

    Time frame: 3 minutes pre-procedure until 1 minute post-procedure, up to 20 minutes

Secondary outcomes

  1. Difference in Visual Analogue Scale (VAS) Pain Score as Measured 3 Minutes Before and Immediately After Intervention

    Difference in VAS pain score as measured 3 minutes before and immediately after intervention. This score is measured on a scale from 0-10, with 10 meaning the worst pain.

    Time frame: 3 minutes before and immediately after intervention

  2. Difference in Visual Analogue Scale (VAS) Anxiety Score as Measured 3 Minutes Before and Immediately After Intervention

    Difference in VAS anxiety score as measured 3 minutes before and immediately after intervention. This score is measured on a scale from 0-10, with 10 meaning the worst anxiety.

    Time frame: 3 minutes before and immediately after intervention

  3. Parent/Guardian Post-procedure Satisfaction Questionnaire Response

    Parent/guardian satisfaction is measured by a question asking the parent/guardian's satisfaction with the entire procedure on a scale from 1-10, where 10 is the most satisfied.

    Time frame: Immediately after intervention

07

Results

Posted Jan 31, 2025

Participant flow

Participant flow — Overall Study
MilestoneA Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.
Started768070
Completed747364
Not completed276
Withdrew: Withdrawal by subject276

Outcome measures

PrimaryAbsolute Difference in HR as Measured 3 Minutes Prior to Procedure and Maximum as Measured During Through 1 Minute After Procedure.

Pulse oximetry application

Time frame:
3 minutes pre-procedure until 1 minute post-procedure, up to 20 minutes
Reported as:
Mean · beats per minute
Absolute Difference in HR as Measured 3 Minutes Prior to Procedure and Maximum as Measured During Through 1 Minute After Procedure.
beats per minuteA Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a Non-VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.
Absolute Difference in HR as Measured 3 Minutes Prior to Procedure and Maximum as Measured During Through 1 Minute After Procedure.20 ± 1620 ± 1621 ± 16
SecondaryDifference in Visual Analogue Scale (VAS) Pain Score as Measured 3 Minutes Before and Immediately After Intervention

Difference in VAS pain score as measured 3 minutes before and immediately after intervention. This score is measured on a scale from 0-10, with 10 meaning the worst pain.

Time frame:
3 minutes before and immediately after intervention

Results for this outcome have not been posted.

SecondaryDifference in Visual Analogue Scale (VAS) Anxiety Score as Measured 3 Minutes Before and Immediately After Intervention

Difference in VAS anxiety score as measured 3 minutes before and immediately after intervention. This score is measured on a scale from 0-10, with 10 meaning the worst anxiety.

Time frame:
3 minutes before and immediately after intervention

Results for this outcome have not been posted.

SecondaryParent/Guardian Post-procedure Satisfaction Questionnaire Response

Parent/guardian satisfaction is measured by a question asking the parent/guardian's satisfaction with the entire procedure on a scale from 1-10, where 10 is the most satisfied.

Time frame:
Immediately after intervention

Results for this outcome have not been posted.

Adverse events

Collected over During the procedure, an average of 30 minutes.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
A Treatment Group That Will Watch a Non-VR Video Via an iPad0/76 (0%)0/76 (0%)0/76 (0%)
A Treatment Group That Will Have Headset on and Will Watch a VR Video0/80 (0%)0/80 (0%)0/80 (0%)
A Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.0/70 (0%)0/70 (0%)0/70 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
<=18 years768070226
Between 18 and 65 years0000
>=65 years0000
Age, Continuous
Age, Continuous(years)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
Mean9 ± 39 ± 39 ± 39 ± 3
Sex: Female, Male
Sex: Female, Male(Participants)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
Female384329110
Male383741116
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
Hispanic or Latino96621
Not Hispanic or Latino606755182
Unknown or Not Reported77923
Race (NIH/OMB)
Race (NIH/OMB)(Participants)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
American Indian or Alaska Native0000
Asian311721
Native Hawaiian or Other Pacific Islander0000
Black or African American55717
White465135132
More than one race0000
Unknown or Not Reported22132156
Region of Enrollment
Region of Enrollment(participants)A Treatment Group That Will Watch a Non-VR Video Via an iPadA Treatment Group That Will Have Headset on and Will Watch a VR VideoA Treatment Group That Will be Immersed in the VR Game (Bear Blast) Via the Headset.Total
United States768070226
08

Study locations

1 site
  • Hospital for Special Surgery
    New York, New York 10021, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 25, 2018

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05510232
Lead sponsor
Hospital for Special Surgery, New York
Responsible party
Sponsor
First posted
Aug 22, 2022
Start date
Jul 25, 2018
Primary completion
May 19, 2022
Completion
May 19, 2022
Results posted
Jan 31, 2025
Last update
Jan 31, 2025

Study contacts

Peter D Fabricant, MD, MPH
principal investigator · Hospital for Special Surgery, New York

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion